Canada Markets closed

Frequency Therapeutics, Inc. (FREQ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.2100-0.1200 (-9.02%)
At close: 04:00PM EDT
1.2700 +0.06 (+4.96%)
After hours: 05:09PM EDT
Sign in to post a message.
  • R
    Rebecca
    Love seeing the company participating in the upcoming HC Wainwright Investors Conference. Excellent exposure!
  • M
    Michael
    If the cilia regeneration works with a reasonable success rate, then the stock will see much more than 10x growth. Tinnitus affects over 45M Americans.FREQ is attacking this with a creative approach. It’s an interesting opportunity
  • E
    Edward
    why no mention of the stockholders class action laws suits here???
  • d
    doug
    OTIC seems to think hearing loss is due to synapse issues rather than hair loss....or maybe along with hair loss. They claim positive hearing in noise results today with their drug OTO-413. their stock is up a little. I'm more curious what the experts here think about their approach
  • A
    A
    Down 90% from IPO

    Enterprise value -36MM

    Trials Ongoing

    Stock has been thrown away with XBI weakness

    Buying the common at these levels is like buying a call option that something (ANYTHING) good will happen in the next two years

    I'm in
  • M
    Marie
    Any of you guys add under $1.50

    like i called it

    sub $1.50 before the weeks out
  • M
    Marie
    no follow through on this mutt.

    Sub $1.50 before the weeks out
  • A
    Anthony
    Retention Bonuses
    On April 11, 2022, the Board of Directors (the "Board") of Frequency Therapeutics, Inc. (the "Company") approved retention bonuses for David Lucchino, President and Chief Executive Officer, Richard Mitrano, Vice President of Finance and Operations, and Wendy Arnold, Chief People Officer (collectively, the "Executives").
    On April 15, 2022, the Company entered into letter agreements with each of Mr. Mitrano and Ms. Arnold (the "Retention Agreements"), pursuant to which Mr. Mitrano and Ms. Arnold are each entitled to receive (i) a payment of $75,000 in cash, payable upon the public disclosure of the results from the Company's Phase 2b clinical trial of FX-322 (FX-322-208), and (ii) a payment of $50,000 in cash, payable within ten days following a determination by the Company's board of directors or an authorized committee thereof of the completion of a bona fide, third-party security financing transaction in which the Company receives gross proceeds of at least $25 million that occurs on or before December 31, 2023 (the "Financing Milestone" and each of (i) and (ii), a "Cash Bonus"). Each Cash Bonus is subject to Mr. Mitrano's and Ms. Arnold's continued employment through the date of payment of such Cash Bonus.
    Mr. Mitrano and Ms. Arnold were also each granted restricted stock units ("RSUs") for 110,000 shares of the Company's common stock, and Mr. Lucchino was granted RSUs for 300,000 shares of the Company's common stock. The RSUs granted to the Executives will vest in full upon the achievement of the Financing Milestone.
    The foregoing description of the material terms of the Retention Agreements is qualified in its entirety by reference to the full agreements, copies of which are filed as exhibits 10.1 and 10.2 to this Current Report on Form 8-K. and are incorporated herein by reference.

    This tells me they all agree #1 it works that we shall see a share price increase because of the results thus being able to pay out the bonuses and by those dates so load up the truck
  • B
    Benjoe
    I am in!
  • A
    Archie
    Never a good sign:
    "On April 8, 2022, Frequency Therapeutics, Inc. (the “Company”) announced a reduction in force (the “Reduction”) of approximately 30% of its workforce."
  • A
    A
    freq getting some attention on reddit
  • H
    Hipsterkicks
    No bad news. Biotech market is down across the board. Freq has a high beta. Stay the course. There does not appear to be any negative indications.
  • r
    richard
    FREQ. HAS $3.74 PER SHARE. IN " CASH"...... AS PER YAHOO...
  • D
    Dodgevilledawg
    With a Market Cap of 50M this will almost certainly double in anticipation of P2 results late 22 early 23. Pure speculation will drive it to a 100M MC pre results IMO. Perfect storm of market dynamics and an extremely poor previous P2 design have combined to make this a highly compelling risk reward. Beginning to build a position this month and will add each month through the year.
  • E
    End
    Are we expecting any announcement/results in the coming days or weeks?
  • D
    Dodgevilledawg
    Is this a reddit run? There is literally no reason for a move of this magnitude. Zero chance of a buyout and no data that could possibly leak to move share price. The fluctuations are crazy and completely unjustified.
  • L
    Larry
    When a stock goes up by over 30 % with no public news it's all pump and dump scheme by the usual suspect of Churchill Swartz & Associates in cahoots with a fake traders from the same group Bam.
  • d
    doug
    Huge volume today. Not much movement tho. weird
  • A
    A
    i must confess i booked todays gains late in the day with the realization that it could go to $2 tomorrow

    If it trades off I'll look to re-enter, if not more power to you guys still holding
  • N
    Nathan
    I think the business is a scam build on dreams and hopes. They don’t have the knowledge and facility to come up with a convincing and working product. Their clinic trials were bs too. Trial volunteers were paid actors, imo.